drugset / Trial / NCT03753776

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women

NCT03753776

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Breast cancer is the second most frequent cancer worldwide. Principal therapy consists in radiotherapy, but this technic has sides effects as radiodermatitis, concerning about 90 percent of women treated. Risk of flushing could be reduced by hygienic rules, but no treatment proved its efficacy to prevent radiodermatitis. Homeopathy is popular but also contested. No clinical trial proved its efficacy for this indication. The present study aims at evaluating Radium bromatum efficacy (homeopathy), compared to placebo, to prevent radiodermatitis apparition for women treated for breast cancer.

Timeline

Start
2019-07-15
Primary completion
2024-01-05
Completion
2024-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Apis mellifica Unknown
Subject Belladonna Unknown
Subject Radium bromatum Traditional medicine (herbal / TCM)

Indications